Publicaciones (22) Publicaciones de MARGARITA GONZALEZ-VALLINAS GARRACHON

2023

  1. Current approaches to develop “off-the-shelf” chimeric antigen receptor (CAR)-T cells for cancer treatment: a systematic review

    Experimental Hematology and Oncology, Vol. 12, Núm. 1

2021

  1. Cell therapy for colorectal cancer: The promise of chimeric antigen receptor (car)‐t cells

    International Journal of Molecular Sciences, Vol. 22, Núm. 21

  2. Long-term efficacy of autologous bone marrow mesenchymal stromal cells for treatment of knee osteoarthritis

    Journal of Translational Medicine

  3. Treatment of Degenerative Disc Disease with Allogeneic Mesenchymal Stem Cells: Long-term Follow-up Results

    Transplantation

2018

  1. Epigenetically regulated chromosome 14q32 miRNA cluster induces metastasis and predicts poor prognosis in lung adenocarcinoma patients

    Molecular Cancer Research, Vol. 16, Núm. 3, pp. 390-402

  2. Tumor Cell Load and Heterogeneity Estimation from Diffusion-Weighted MRI Calibrated with Histological Data: An Example from Lung Cancer

    IEEE Transactions on Medical Imaging, Vol. 37, Núm. 1, pp. 35-46

2016

  1. MicroRNAs are key regulators of hepatocellular carcinoma (HCC) cell dissemination - what we learned from microRNA-494

    HEPATOBILIARY SURGERY AND NUTRITION

  2. Patch-Based Nonlinear Image Registration for Gigapixel Whole Slide Images

    IEEE Transactions on Biomedical Engineering, Vol. 63, Núm. 9, pp. 1812-1819

  3. Quantitative estimation of tumor cellularity based on histology data

    2016 IEEE Nuclear Science Symposium, Medical Imaging Conference and Room-Temperature Semiconductor Detector Workshop, NSS/MIC/RTSD 2016

2015

  1. Clinical relevance of the differential expression of the glycosyltransferase gene GCNT3 in colon cancer

    European Journal of Cancer, Vol. 51, Núm. 1, pp. 1-8

  2. ColoLipidGene: Signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients

    Oncotarget, Vol. 6, Núm. 9, pp. 7348-7363

  3. Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cells

    Journal of Pathology, Vol. 237, Núm. 3, pp. 390-401

  4. Rosemary (Rosmarinus officinalis L.) Extract as a Potential Complementary Agent in Anticancer Therapy

    Nutrition and Cancer, Vol. 67, Núm. 8, pp. 1223-1231

  5. The Ellagic Acid Derivative 4,4′-Di-O-Methylellagic Acid Efficiently Inhibits Colon Cancer Cell Growth through a Mechanism Involving WNT16

    Journal of Pharmacology and Experimental Therapeutics, Vol. 353, Núm. 2, pp. 433-444

2014

  1. Expression of MicroRNA-15b and the glycosyltransferase GCNT3 correlates with antitumor efficacy of rosemary diterpenes in colon and pancreatic cancer

    PLoS ONE, Vol. 9, Núm. 6

  2. Genes associated with metabolic syndrome predict disease-free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer

    Molecular Oncology, Vol. 8, Núm. 8, pp. 1469-1481

  3. Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells

    Electrophoresis, Vol. 35, Núm. 11, pp. 1719-1727

2013

  1. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells

    Pharmacological Research, Vol. 72, pp. 61-68

  2. Dietary phytochemicals in cancer prevention and therapy: A complementary approach with promising perspectives

    Nutrition Reviews, Vol. 71, Núm. 9, pp. 585-599

  3. Supercritical rosemary extracts, their antioxidant activity and effect on hepatic tumor progression

    Journal of Supercritical Fluids, Vol. 79, pp. 101-108